Sodium hydrosulfide moderately alleviates the hallmark symptoms of Duchenne muscular dystrophy in mdx mice.
DMD
Duchenne muscular dystrophy
Hydrogen sulfide
NaHS
Sodium hydrosulfide
mdx
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
15 Sep 2023
15 Sep 2023
Historique:
received:
22
11
2022
revised:
22
06
2023
accepted:
18
07
2023
pubmed:
29
7
2023
medline:
29
7
2023
entrez:
28
7
2023
Statut:
ppublish
Résumé
Duchenne muscular dystrophy (DMD) is an incurable disease caused by mutations in the X-linked DMD gene that encodes a structural muscle protein, dystrophin. This, in turn, leads to progressive degeneration of the skeletal muscles and the heart. Hydrogen sulfide (H
Identifiants
pubmed: 37507045
pii: S0014-2999(23)00440-5
doi: 10.1016/j.ejphar.2023.175928
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
175928Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that there are no competing interests associated with the manuscript.